Articles |
From the Department of Biochemistry and Pathology, Boston (Mass) University School of Medicine.
Correspondence to Peter Brecher, PhD, Department of Biochemistry and Pathology, Boston University School of Medicine, Whitaker Cardiovascular Institute, 80 East Concord St, Boston, MA 02118. E-mail pbrecher@acs.bu.edu.
Abstract To determine if fibroblasts are a source of NO
in inflammatory myocardial diseases, we have studied the effect of
cytokines on the inducible NO synthase (iNOS) in neonatal
cardiac fibroblasts and tested whether nonsteroidal
anti-inflammatory drugs can diminish the induction of iNOS. In
primary cultures, interferon gamma (IFN), interleukin-1ß (IL-1), or
tumor necrosis factor-
(TNF) separately did not stimulate nitrite
production, whereas IFN combined with IL-1 or TNF
synergistically induced iNOS, both at the level of steady state mRNA
and nitrite accumulation. Steady state mRNA levels for iNOS were
obvious as early as 3 hours after the addition of IFN+TNF and remained
elevated for at least 72 hours. Sodium salicylate inhibited
cytokine-induced nitrite accumulation in a time- and
dose-dependent manner (IC50, 750 µmol/L). The
inhibition was reversible and occurred when salicylate was added either
before or after cytokine induction. Aspirin (1 mmol/L) also
inhibited nitrite production, whereas
indomethacin (25 µmol/L) or acetaminophen
(100 µmol/L) did not. TNF, either alone or combined with IFN,
significantly stimulated prostaglandin
E2, which was inhibited by either salicylate (4
mmol/L) or indomethacin (25 µmol/L). Salicylate, when
given either before or after IFN+TNF, reduced mRNA levels of iNOS
induced by cytokines. Salicylate did not affect iNOS enzymatic
activity when added to the cytosolic lysate, although it was able to
reduce enzymatic activity to 32% of induced levels when given to
intact cells. These studies implicate cardiac fibroblasts as a source
of NO in inflammatory cardiac diseases and suggest a possible
therapeutic role for salicylate and aspirin in diminishing the steady
state levels of iNOS mRNA.
Key Words: nitric oxide fibrosis prostaglandins cell culture
This article has been cited by other articles:
![]() |
X. Xu, J. Pang, H. Yin, M. Li, W. Hao, C. Chen, and J.-M. Cao Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2952 - H2958. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Libert, J. Bonnefont, E. Bourinet, E. Doucet, A. Alloui, M. Hamon, J. Nargeot, and A. Eschalier Acetaminophen: A Central Analgesic Drug That Involves a Spinal Tropisetron-Sensitive, Non-5-HT3 Receptor-Mediated Effect Mol. Pharmacol., September 1, 2004; 66(3): 728 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Farivar, L. H. Cohn, E. G. Soltesz, T. Mihaljevic, J. D. Rawn, and J. G. Byrne Transcriptional profiling and growth kinetics of endothelium reveals differences between cells derived from porcine aorta versus aortic valve Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Safety Assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate International Journal of Toxicology, June 1, 2003; 22(3_suppl): 1 - 108. [Abstract] [PDF] |
||||
![]() |
R. S. Farivar, F. Filsoufi, and D. H. Adams Mechanisms of Gal{alpha}1-3Gal{beta}1-4GlcNAc-R ({alpha}Gal) expression on porcine valve endothelial cells J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 306 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tian, J. Liu, P. B. Bitterman, and R. J. Bache Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1958 - H1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Giuliano, J. A. Mitchell, and T. D. Warner Sodium Salicylate Inhibits Prostaglandin Formation without Affecting the Induction of Cyclooxygenase-2 by Bacterial Lipopolysaccharide in Vivo J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 894 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Gustafsson and L. L. Brunton beta -Adrenergic Stimulation of Rat Cardiac Fibroblasts Enhances Induction of Nitric-Oxide Synthase by Interleukin-1beta via Message Stabilization Mol. Pharmacol., April 13, 2001; 58(6): 1470 - 1478. [Abstract] [Full Text] |
||||
![]() |
Z. Wang and P. Brecher Salicylate Inhibits Phosphorylation of the Nonreceptor Tyrosine Kinases, Proline-Rich Tyrosine Kinase 2 and c-Src Hypertension, January 1, 2001; 37(1): 148 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimpo, U. Ikeda, Y. Maeda, K.-i. Ohya, Y. Murakami, and K. Shimada Effects of Aspirin-Like Drugs on Nitric Oxide Synthesis in Rat Vascular Smooth Muscle Cells Hypertension, May 1, 2000; 35(5): 1085 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, X. Yu, R. A. Cohen, and P. Brecher Distinct Effects of N-Acetylcysteine and Nitric Oxide on Angiotensin II-induced Epidermal Growth Factor Receptor Phosphorylation and Intracellular Ca2+ Levels J. Biol. Chem., April 14, 2000; 275(16): 12223 - 12230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kitakaze, H. Asanuma, S. Takashima, T. Minamino, Y. Ueda, Y. Sakata, M. Asakura, S. Sanada, T. Kuzuya, and M. Hori Nifedipine-Induced Coronary Vasodilation in Ischemic Hearts Is Attributable to Bradykinin- and NO-Dependent Mechanisms in Dogs Circulation, January 25, 2000; 101(3): 311 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang and P. Brecher Salicylate Inhibition of Extracellular Signal-Regulated Kinases and Inducible Nitric Oxide Synthase Hypertension, December 1, 1999; 34(6): 1259 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang, M. Haverty, and P. Brecher N-Acetyl-L-Cysteine Enhances Interleukin-1{beta}-Induced Nitric Oxide Synthase Expression Hypertension, October 1, 1999; 34(4): 574 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, X. Yu, and P. Brecher Nitric Oxide Inhibits Angiotensin II-induced Activation of the Calcium-sensitive Tyrosine Kinase Proline-rich Tyrosine Kinase 2 without Affecting Epidermal Growth Factor Receptor Transactivation J. Biol. Chem., August 20, 1999; 274(34): 24342 - 24348. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Vandivier, A. Eidsath, S. M. Banks, H. L. Preas II, S. B. Leighton, P. J. Godin, A. F. Suffredini, and R. L. Danner Down-Regulation of Nitric Oxide Production by Ibuprofen in Human Volunteers J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1398 - 1403. [Abstract] [Full Text] |
||||
![]() |
K. Katsuyama, M. Shichiri, H. Kato, T. Imai, F. Marumo, and Y. Hirata Differential Inhibitory Actions by Glucocorticoid and Aspirin on Cytokine-Induced Nitric Oxide Production in Vascular Smooth Muscle Cells Endocrinology, May 1, 1999; 140(5): 2183 - 2190. [Abstract] [Full Text] |
||||
![]() |
D. Wang, X. Yu, and P. Brecher Nitric Oxide and N-Acetylcysteine Inhibit the Activation of Mitogen-activated Protein Kinases by Angiotensin II in Rat Cardiac Fibroblasts J. Biol. Chem., December 4, 1998; 273(49): 33027 - 33034. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Katsuyama, M. Shichiri, F. Marumo, and Y. Hirata NO Inhibits Cytokine-Induced iNOS Expression and NF-{kappa}B Activation by Interfering With Phosphorylation and Degradation of I{kappa}B-{alpha} Arterioscler Thromb Vasc Biol, November 1, 1998; 18(11): 1796 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harms, I. Ramirez, and H. Peña-Cortés Inhibition of Wound-Induced Accumulation of Allene Oxide Synthase Transcripts in Flax Leaves by Aspirin and Salicylic Acid Plant Physiology, November 1, 1998; 118(3): 1057 - 1065. [Abstract] [Full Text] |
||||
![]() |
R. K. Dubey, D. G. Gillespie, and E. K. Jackson Adenosine Inhibits Collagen and Protein Synthesis in Cardiac Fibroblasts : Role of A2B Receptors Hypertension, April 1, 1998; 31(4): 943 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. LaPointe and J. R. Sitkins Phospholipase A2 Metabolites Regulate Inducible Nitric Oxide Synthase in Myocytes Hypertension, January 1, 1998; 31(1): 218 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pagano, J. K. Clark, M. E. Cifuentes-Pagano, S. M. Clark, G. M. Callis, and M. T. Quinn Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II PNAS, December 23, 1997; 94(26): 14483 - 14488. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takizawa, M. Gu, A. V. Chobanian, and P. Brecher Effect of Nitric Oxide on DNA Replication Induced by Angiotensin II in Rat Cardiac Fibroblasts Hypertension, November 1, 1997; 30(5): 1035 - 1040. [Abstract] [Full Text] |
||||
![]() |
R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Exogenous and Endogenous Adenosine Inhibits Fetal Calf Serum–Induced Growth of Rat Cardiac Fibroblasts : Role of A2B Receptors Circulation, October 21, 1997; 96(8): 2656 - 2666. [Abstract] [Full Text] |
||||
![]() |
J.-L. Balligand and P. J. Cannon Nitric Oxide Synthases and Cardiac Muscle : Autocrine and Paracrine Influences Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1846 - 1858. [Abstract] [Full Text] |
||||
![]() |
G. Kwon, J. R. Hill, J. A. Corbett, and M. L. McDaniel Effects of Aspirin on Nitric Oxide Formation and De Novo Protein Synthesis by RINm5F Cells and Rat Islets Mol. Pharmacol., September 1, 1997; 52(3): 398 - 405. [Abstract] [Full Text] |
||||
![]() |
R. S. Farivar and P. Brecher Salicylate Is a Transcriptional Inhibitor of the Inducible Nitric Oxide Synthase in Cultured Cardiac Fibroblasts J. Biol. Chem., December 6, 1996; 271(49): 31585 - 31592. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kelly, J.-L. Balligand, and T. W. Smith Nitric Oxide and Cardiac Function Circ. Res., September 1, 1996; 79(3): 363 - 380. [Full Text] |
||||
![]() |
A. M. Silva and L. F. L. Reis Sodium Salicylate Induces the Expression of the Immunophilin FKBP51 and Biglycan Genes and Inhibits p34cdc2 mRNA Both in Vitro and in Vivo J. Biol. Chem., November 10, 2000; 275(46): 36388 - 36393. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |